SCHEMBL31240428

SCHEMBL31240428

Nc1n[nH]c2ccc(-c3ccnc(NCCc4cccc(Cl)c4)c3)cc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 8/20 0.57
▸ MAPK1 P28482 3/20 0.48
▸ MKNK1 Q9BUB5 1/20 0.43
▸ MKNK2 Q9HBH9 1/20 0.43
▸ GRM4 Q14833 1/20 0.43
▸ EGFR P00533 1/20 0.42
▸ IGF1R P08069 1/20 0.42
▸ LRRK2 Q5S007 1/20 0.42
▸ JAK1 P23458 2/20 0.42
▸ JAK3 P52333 2/20 0.42
▸ TYK2 P29597 1/20 0.42
▸ CDC7 O00311 2/20 0.41
▸ CDK2 P24941 2/20 0.41
▸ CCNE1 P24864 1/20 0.41
▸ DBF4 Q9UBU7 1/20 0.41
▸ MAPK3 P27361 1/20 0.41
▸ CSNK2A1 P68400 3/20 0.40
▸ AURKA O14965 1/20 0.40
▸ CHUK O15111 1/20 0.40
▸ MAPK13 O15264 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240447 0.89 JAK2 (0.48) JAK2MKNK2LRRK2JAK1JAK3
SCHEMBL31240716 0.88 JAK2 (0.54) JAK2MAPK1MKNK1MKNK2LRRK2
SCHEMBL31240513 0.84 PIM1 (0.50) JAK2MKNK1MKNK2LRRK2CDC7
SCHEMBL31240406 0.84 JAK2 (0.60) JAK2MAPK1MKNK1MKNK2LRRK2
SCHEMBL31240512 0.82 JAK2 (0.52) JAK2MAPK1MKNK2LRRK2JAK1
SCHEMBL31240368 0.82 JAK2 (0.48) JAK2MAPK1MKNK2LRRK2JAK3
SCHEMBL31240674 0.82 JAK2 (0.48) JAK2MAPK1MKNK2LRRK2JAK3
SCHEMBL31240399 0.81 JAK2 (0.54) JAK2MAPK1MKNK1MKNK2JAK1
SCHEMBL31240411 0.80 CDC7 (0.58) JAK2MAPK1MKNK1MKNK2LRRK2
SCHEMBL31240309 0.80 CYP1A2 (0.50) JAK2MAPK1MKNK2LRRK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback